Trial intelligence / Profile preview

Opioid-Free Spontaneous Breathing Anesthesia for VATS

NCT06367218Recruiting

Sponsor
Tongji Hospital
Start
Oct 2024
Primary completion
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of esketamine in pulmonary nodules (SPN) (4 arms), sponsored by Tongji Hospital. Primary endpoint: Lung function 30 days after surgery. Started Oct 2024; status: recruiting.

02

Drugs

esketamine
03

Conditions

pulmonary nodules (SPN)

Beyond the preview

Go deeper on NCT06367218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06367218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call